Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 574-582

  Li, Haiyan ^a   Lindholm, Eero ^a   Almgren, Peter ^a   Gustafsson, Åsa ^a   Forsblom, Carol ^b   Groop, Leif ^a   Tuomi, Tiinamaija ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL;

AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GENOTYPE; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; INSULIN; MALE; MIDDLE AGED;

EID: 0035092748     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.2.574     Document Type: Article

References (56)

1. The Swedish childhood diabetes study-results from a nine-year case register and a one-year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmtme disorders
2. Clinical remission in patients with IDDM and family history of NIDDM
3. Epidemiological evidence for "double diabetes"
4. Decreased insulin response to glucose in islet cell antibody-negative siblings of type 1 diabetic children
5. Diabetes in offspring and siblings of juvenile- and maturityonset-type diabetics
6. Heterogeneity of diabetes mellitus
7. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden
8. Empirical risk for insulin-dependent diabetes (IDD) in sibs. Further definition of genetic heterogeneity
9. The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM
10. The impact of a family history of type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with type I (insulin-dependent) diabetes mellitus
11. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
12. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type
13. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis
14. UKPDS: Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
15. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies
16. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes
17. Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes
18. HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: The Wadena City Health Study
19. Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region
20. Genetic heterogeneity of autoimmune diabetes: Age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group
21. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: Contributions of HLA and haptoglobin
22. Metabolic consequences of a family history of NIDDM (the Botnia study): Evidence for sex-specific parental effects
23. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
24. Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect
25. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles
26. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study
27. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique
28. An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests
29. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Belgian Diabetes Registry
30. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families
31. Complete multipoint sib-pair analysis of qualitative and quantitative traits
32. Clinical and metabolic characteristics of type 1 and type 2 diabetes: An epidemiological study from the Narpes community in western Finland
33. Family histories of diabetes among Japanese patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes
34. Familial aggregation in type 1 (insulin-dependent) diabetes mellitus: A study from south India
35. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes
36. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group
37. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes
38. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes
39. Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic Individuals indicate high risk for impaired beta-cell function
40. Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population
41. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry
42. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes
43. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes
44. Risk factors for mortality in type II (non-insulin-dependent) diabetes: Evidence of a role for neuropathy and a protective effect of HLA-DR4
45. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
46. Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients
47. Long-term risk of IDDM in first-degree relatives of patients with IDDM
48. Predicting insulin-dependent diabetes
49. Epidemiology of childhood diabetes mellitus in Finland-background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group
50. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus
51. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion
52. Risk of diabetes in siblings and other relatives of IDDM subjects
53. Can future type I diabetes be predicted? A study in families of affected children
54. The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Study. HLA antigens and haplotypes as risk factors for the development of IDDM in IDDM patients and their siblings
55. Genetic structure of IDDMI: Two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry
56. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene